Company
FINEHEART
- Biotech
- Headquarters:
- Pessac
Description
Develops FlowMaker®, an implantable therapy platform for treating advanced heart failure, used by clinicians and health systems managing severe cardiology patients.
Related
FIRE1Builds heart-failure care tools for restoring patients' everyday health and function; used by clinicians and patients managing heart…
CorWave SADevelops implantable left ventricular assist pumps using a wave membrane to provide truly pulsatile blood flow for patients with advanced…
CarTheraCarthera designs ultrasound-based medical devices that temporarily open the blood–brain barrier for treating glioblastoma and other severe…
CroíValveCroíValve develops a minimally invasive tricuspid heart valve device.
INBRAIN NEUROELECTRONICSINBRAIN Neuroelectronics develops graphene-based brain-computer interface technology.
Max Planck Institute for Heart and Lung ResearchConducts biomedical research on heart and lung biology and disease for use by the scientific and medical research community and clinicians.
Esperion Therapeutics ($ESPR)Develops and commercializes medicines for cardiovascular disease, including cholesterol management, cardiovascular risk reduction, and…
Synapse MedicineDevelops medical AI tools and databases for clinical use; designed for healthcare professionals and clinical software integrators to secure…
RobeautéBuilds a microrobotic platform intended to improve surgery; used for understanding and treating brain disease and supporting neurosurgery…
Intelligent Therapeutics, Inc.Engineers antibodies and antibody-like molecules for treating solid tumors and rare autoimmune diseases, with pipeline work in companion…
Neuromod DevicesDevelops the Lenire bimodal neuromodulation tinnitus treatment device for clinicians and patients seeking tinnitus care across Europe and…
AntabioAntabio develops antibacterial medicines for drug-resistant bacterial infections.